Inflammation and coagulation in urticaria and angioedema

Massimo Cugno, Riccardo Asero, Alberto Tedeschi, Riccardo Lazzari, Angelo V. Marzano

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Urticaria is a skin disease characterised by short-lived surface swellings of the dermis (wheals) frequently accompanied by itching. It is classified as acute or chronic depending on whether the wheal recurrence occurs for less or more than six weeks. Acute urticaria is often due to a hypersensitivity reaction, whereas about 50% of the cases of chronic urticaria are regarded as autoimmune. Urticaria may occur alone or in association with a deeper swelling (angioedema) involving the subcutaneous and/or submucosal tissues, and last from hours to a few days. Angioedema can also develop alone, and may be idiopathic or be caused by allergies, inherited or acquired deficiencies of C1-inhibitor protein, or adverse drug reactions. An interplay between inflammation and coagulation has been proposed as a pathomechanism in urticaria and urticaria-associated angioedema (in which histamine and thrombin are involved), as well as in angioedema due to C1-inhibitor deficiency, which involves various biological systems. An increase in the plasma markers of thrombin generation, fibrinolysis and inflammation has been documented during exacerbations of urticaria and angioedema, with the marker levels decreasing to normal during remission. However, the hypercoagulable state in chronic urticaria and angioedema has not been reported to be associated with any increased risk of thrombosis, although there have been a number of reports of cardiovascular events occurring during episodes of acute urticaria. These observations have provided the rationale for the clinical evaluation of anticoagulant and antifibrinolytic drugs, the efficacy of which has sometimes been demonstrated.

Original languageEnglish
Pages (from-to)653-658
Number of pages6
JournalCurrent Vascular Pharmacology
Volume10
Issue number5
DOIs
Publication statusPublished - 2012

Fingerprint

Angioedema
Urticaria
Inflammation
Thrombin
Hypersensitivity
Complement C1 Inhibitor Protein
Hereditary Angioedemas
Antifibrinolytic Agents
Fibrinolysis
Pruritus
Dermis
Drug-Related Side Effects and Adverse Reactions
Skin Diseases
Anticoagulants
Histamine
Thrombosis
Recurrence

Keywords

  • Angioedema
  • C1-inhibitor deficiency
  • Histamine
  • Thrombin
  • Tissue factor
  • Urticaria

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Inflammation and coagulation in urticaria and angioedema. / Cugno, Massimo; Asero, Riccardo; Tedeschi, Alberto; Lazzari, Riccardo; Marzano, Angelo V.

In: Current Vascular Pharmacology, Vol. 10, No. 5, 2012, p. 653-658.

Research output: Contribution to journalArticle

Cugno, Massimo ; Asero, Riccardo ; Tedeschi, Alberto ; Lazzari, Riccardo ; Marzano, Angelo V. / Inflammation and coagulation in urticaria and angioedema. In: Current Vascular Pharmacology. 2012 ; Vol. 10, No. 5. pp. 653-658.
@article{d4e45e6328db40899ac30f1e8ccf8cbe,
title = "Inflammation and coagulation in urticaria and angioedema",
abstract = "Urticaria is a skin disease characterised by short-lived surface swellings of the dermis (wheals) frequently accompanied by itching. It is classified as acute or chronic depending on whether the wheal recurrence occurs for less or more than six weeks. Acute urticaria is often due to a hypersensitivity reaction, whereas about 50{\%} of the cases of chronic urticaria are regarded as autoimmune. Urticaria may occur alone or in association with a deeper swelling (angioedema) involving the subcutaneous and/or submucosal tissues, and last from hours to a few days. Angioedema can also develop alone, and may be idiopathic or be caused by allergies, inherited or acquired deficiencies of C1-inhibitor protein, or adverse drug reactions. An interplay between inflammation and coagulation has been proposed as a pathomechanism in urticaria and urticaria-associated angioedema (in which histamine and thrombin are involved), as well as in angioedema due to C1-inhibitor deficiency, which involves various biological systems. An increase in the plasma markers of thrombin generation, fibrinolysis and inflammation has been documented during exacerbations of urticaria and angioedema, with the marker levels decreasing to normal during remission. However, the hypercoagulable state in chronic urticaria and angioedema has not been reported to be associated with any increased risk of thrombosis, although there have been a number of reports of cardiovascular events occurring during episodes of acute urticaria. These observations have provided the rationale for the clinical evaluation of anticoagulant and antifibrinolytic drugs, the efficacy of which has sometimes been demonstrated.",
keywords = "Angioedema, C1-inhibitor deficiency, Histamine, Thrombin, Tissue factor, Urticaria",
author = "Massimo Cugno and Riccardo Asero and Alberto Tedeschi and Riccardo Lazzari and Marzano, {Angelo V.}",
year = "2012",
doi = "10.2174/157016112801784558",
language = "English",
volume = "10",
pages = "653--658",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Inflammation and coagulation in urticaria and angioedema

AU - Cugno, Massimo

AU - Asero, Riccardo

AU - Tedeschi, Alberto

AU - Lazzari, Riccardo

AU - Marzano, Angelo V.

PY - 2012

Y1 - 2012

N2 - Urticaria is a skin disease characterised by short-lived surface swellings of the dermis (wheals) frequently accompanied by itching. It is classified as acute or chronic depending on whether the wheal recurrence occurs for less or more than six weeks. Acute urticaria is often due to a hypersensitivity reaction, whereas about 50% of the cases of chronic urticaria are regarded as autoimmune. Urticaria may occur alone or in association with a deeper swelling (angioedema) involving the subcutaneous and/or submucosal tissues, and last from hours to a few days. Angioedema can also develop alone, and may be idiopathic or be caused by allergies, inherited or acquired deficiencies of C1-inhibitor protein, or adverse drug reactions. An interplay between inflammation and coagulation has been proposed as a pathomechanism in urticaria and urticaria-associated angioedema (in which histamine and thrombin are involved), as well as in angioedema due to C1-inhibitor deficiency, which involves various biological systems. An increase in the plasma markers of thrombin generation, fibrinolysis and inflammation has been documented during exacerbations of urticaria and angioedema, with the marker levels decreasing to normal during remission. However, the hypercoagulable state in chronic urticaria and angioedema has not been reported to be associated with any increased risk of thrombosis, although there have been a number of reports of cardiovascular events occurring during episodes of acute urticaria. These observations have provided the rationale for the clinical evaluation of anticoagulant and antifibrinolytic drugs, the efficacy of which has sometimes been demonstrated.

AB - Urticaria is a skin disease characterised by short-lived surface swellings of the dermis (wheals) frequently accompanied by itching. It is classified as acute or chronic depending on whether the wheal recurrence occurs for less or more than six weeks. Acute urticaria is often due to a hypersensitivity reaction, whereas about 50% of the cases of chronic urticaria are regarded as autoimmune. Urticaria may occur alone or in association with a deeper swelling (angioedema) involving the subcutaneous and/or submucosal tissues, and last from hours to a few days. Angioedema can also develop alone, and may be idiopathic or be caused by allergies, inherited or acquired deficiencies of C1-inhibitor protein, or adverse drug reactions. An interplay between inflammation and coagulation has been proposed as a pathomechanism in urticaria and urticaria-associated angioedema (in which histamine and thrombin are involved), as well as in angioedema due to C1-inhibitor deficiency, which involves various biological systems. An increase in the plasma markers of thrombin generation, fibrinolysis and inflammation has been documented during exacerbations of urticaria and angioedema, with the marker levels decreasing to normal during remission. However, the hypercoagulable state in chronic urticaria and angioedema has not been reported to be associated with any increased risk of thrombosis, although there have been a number of reports of cardiovascular events occurring during episodes of acute urticaria. These observations have provided the rationale for the clinical evaluation of anticoagulant and antifibrinolytic drugs, the efficacy of which has sometimes been demonstrated.

KW - Angioedema

KW - C1-inhibitor deficiency

KW - Histamine

KW - Thrombin

KW - Tissue factor

KW - Urticaria

UR - http://www.scopus.com/inward/record.url?scp=84864550881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864550881&partnerID=8YFLogxK

U2 - 10.2174/157016112801784558

DO - 10.2174/157016112801784558

M3 - Article

C2 - 22272913

AN - SCOPUS:84864550881

VL - 10

SP - 653

EP - 658

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 5

ER -